GVHD prophylaxis made safe, easy, and inexpensive

In this issue of Blood, Kanakry and coworkers report on the use of posttransplant cyclophosphamide (Cy) as sole immunoprophylaxis against graft-versus-host disease (GVHD) in HLA-matched related or unrelated allogeneic hematopoietic stem cell transplant (HSCT).

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Blood 2014-12, Vol.124 (25), p.3672-3673
1. Verfasser:	Ringden, O
Format:	Artikel
Sprache:	eng
Schlagworte:	Bone Marrow Transplantation - methods Cyclophosphamide - therapeutic use Female Graft vs Host Disease - prevention & control Humans Leukemia, Myeloid - therapy Male Medicin och hälsovetenskap Myelodysplastic Syndromes - therapy Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	In this issue of Blood, Kanakry and coworkers report on the use of posttransplant cyclophosphamide (Cy) as sole immunoprophylaxis against graft-versus-host disease (GVHD) in HLA-matched related or unrelated allogeneic hematopoietic stem cell transplant (HSCT).
ISSN:	0006-4971 1528-0020 1528-0020
DOI:	10.1182/blood-2014-10-607879